Your browser doesn't support javascript.
loading
The Thioredoxin-Interacting Protein TXNIP Is a Putative Tumour Suppressor in Cutaneous T-Cell Lymphoma.
Stolearenco, Veronica; Levring, Trine B; Nielsen, Helene Myrtue; Lindahl, Lise; Fredholm, Simon; Kongsbak-Wismann, Martin; Willerslev-Olsen, Andreas; Buus, Terkild B; Nastasi, Claudia; Hu, Tengpeng; Gluud, Maria; Côme, Christophe R M; Krejsgaard, Thorbjørn; Iversen, Lars; Bonefeld, Charlotte Menné; Grønbæk, Kirsten; Met, Özcan; Woetmann, Anders; Ødum, Niels; Geisler, Carsten.
Afiliação
  • Stolearenco V; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Levring TB; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Nielsen HM; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Lindahl L; Biotech Research and Innovation Center (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Fredholm S; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
  • Kongsbak-Wismann M; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Willerslev-Olsen A; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Buus TB; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Nastasi C; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Hu T; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Gluud M; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Côme CRM; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Krejsgaard T; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Iversen L; Biotech Research and Innovation Center (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Bonefeld CM; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Grønbæk K; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
  • Met Ö; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Woetmann A; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Ødum N; Biotech Research and Innovation Center (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Geisler C; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Dermatology ; 237(2): 283-290, 2021.
Article em En | MEDLINE | ID: mdl-32799209
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Proteínas de Transporte / Linfoma Cutâneo de Células T Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Proteínas de Transporte / Linfoma Cutâneo de Células T Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article